A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy
- 6 January 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 93 (1107) , 20190845
Abstract
Objectives: The purpose of this study is to investigate the dosimetric effect and clinical impact of delivering a focal radiotherapy boost dose to multiparametric MRI (mp-MRI)-defined dominant intraprostatic lesions (DILs) in prostate cancer using proton therapy. Methods: We retrospectively investigated 36 patients with pre-treatment mp-MRI and CT images who were treated using pencil beam scanning (PBS) proton radiation therapy to the whole prostate. DILs were contoured on co-registered mp-MRIs. Simultaneous integrated boost (SIB) plans using intensity-modulated proton therapy (IMPT) were created based on conventional whole-prostate-irradiation for each patient and optimized with additional DIL coverage goals and urethral constraints. DIL dose coverage and organ-at-risk (OAR) sparing were compared between conventional and SIB plans. Tumor control probability (TCP) and normal tissue complication probability (NTCP) were estimated to evaluate the clinical impact of the SIB plans. Results: Optimized SIB plans significantly escalated the dose to DILs while meeting OAR constraints. SIB plans were able to achieve 125, 150 and 175% of prescription dose coverage in 74, 54 and 17% of 36 patients, respectively. This was modeled to result in an increase in DIL TCP by 7.3–13.3% depending on α/β and DIL risk level. Conclusion: The proposed mp-MRI-guided DIL boost using proton radiation therapy is feasible without violating OAR constraints and demonstrates a potential clinical benefit by improving DIL TCP. This retrospective study suggested the use of IMPT-based DIL SIB may represent a strategy to improve tumor control. Advances in knowledge: This study investigated the planning of mp-MRI-guided DIL boost in prostate proton radiation therapy and estimated its clinical impact with respect to TCP and NTCP.Keywords
This publication has 71 references indexed in Scilit:
- 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability studyRadiation Oncology, 2013
- The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancerJournal of Radiation Research, 2013
- Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapyRadiation Oncology, 2012
- Does Local Recurrence of Prostate Cancer After Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Parameters Favorable to Intraprostatic Radiation Dose Escalation in Men With Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation Dose–Volume Effects in Radiation-Induced Rectal InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation Dose–Volume Effects of the Urinary BladderInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Regarding the Focal Treatment of Prostate Cancer: Inference of the Gleason Grade From Magnetic Resonance Spectroscopic ImagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Reporting and analyzing dose distributions: A concept of equivalent uniform doseMedical Physics, 1997